1 min read
AGC Biologics Offers Virtual Tour of Expanded Milan Cell & Gene Therapy Center During European Biotech Week 2021
AGC Biologics September 17, 2021 at 1:34 AM
- Elisa Focchi, our Upstream Vector Development Technician, will walk you through key features of our upstream vector manufacturing capabilities. She will show you the equipment required for producing viral vectors and share strategies we follow to provide our partners with the highest quality of product possible.
- Samuele Corbetta, a Downstream Vector Development Specialist, will explain our downstream vector manufacturing process, its importance, and how purification processes play a crucial role in developing the final product yield.
- Paola Terreni, a Cell Process Development Specialist, and Linda Calzolari, a Quality Control Technician, will present AGC Biologics’ cell engineering capabilities. These experts will highlight the equipment and procedures necessary for gene editing and the manufacturing of cells, which are utilized in treatments that help cure rare diseases and cancers.
- Lastly, our Analytics Method Development Technician, Matteo Pennati, and two of our Quality Control Technicians, Gloria Negri and Mattia Ferrarese, will highlight our analytics capabilities. AGC Biologics has invested heavily in building industry-leading analytical services. We provide more than 95% of analytical methods (˜160 tests) in-house, ensuring accuracy and a fast turnaround to help you bring your product to market.
Industry Learnings: Mastering Large-Scale GMP Vector Manufacturing
Video: BIO-Europe 2020 Presentation: AGC Biologics' Capabilities and Introduction to Cell and Gene Therapy
Byron Kneller, VP, Process Development, Seattle and Luca Alberici, General Manager, Milan, present AGC Biologics’ end-to-end CDMO protein expression...
1 min read
AGC Biologics Solves Capacity Shortages in Cell and Gene Therapy Space
The cell and gene therapy (C>) market is experiencing an explosion of growth with record-breaking financing, major clinical milestones, and...
On-Demand Roundtable: Streaming and Optimizing Viral Vector Bioprocess and Analytical Development
Join AGC Biologics' own Mark Womack, Chief Business Officer and Ramin Baghirzade, Sr. Director and Global Cell and Gene Therapy (C>) Business...